Status:

WITHDRAWN

Profiling Fecal Samples for Selection of Donors of Feces

Lead Sponsor:

Assistance Publique - Hôpitaux de Paris

Collaborating Sponsors:

Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement

University of Paris 5 - Rene Descartes

Conditions:

Fecal Microbiota Transplantation

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Fecal microbiota transplantation (FMT) represents a promising therapeutic in numerous clinical situations associated with dysbiosis. Today, this procedure is recommended in patients with recurrent Clo...

Detailed Description

Fecal microbiota transplantation (FMT) represents a promising therapeutic in numerous clinical situations associated with dysbiosis. Today, this procedure is recommended in patients with recurrent Clo...

Eligibility Criteria

Inclusion

  • Age ≥ 18 years
  • Healthy volunteers
  • Participant having been informed of the study and having sign a consent to participation
  • Patient affiliated with a social security or beneficiary of such a social protection

Exclusion

  • Person subject to legal protection (guardianship, trusteeship, etc.)
  • Chronic disease that can alter the intestinal microbiota: cancer or malignant disease, bowel disease, diabetes, hypertension, hypercholesterolemia, ....
  • Presence in the 1st degree family of one of the chronic diseases mentioned above
  • Blood in stools
  • Chronic drug treatment likely to alter the intestinal microbiota
  • Travel to a tropical country in the last 3 months or extended stay (\> 3 months) for less than 1 year
  • Hospitalization abroad (\> 24h) in the last 12 months
  • Hospitalization abroad (\> 24h) of a family member living under the same roof during the last 12 months
  • Medical consultation in the last 3 months (other than administrative)
  • Contact with a person with an infectious or contagious disease for more than 3 months
  • Digestive disorders / febrile gastroenteritis (diarrhea with fever) in the last 3 months
  • Febrile illnesses for more than 3 months
  • Antibiotic treatment in the last 3 months
  • Treatment with PPIs in the last 3 months

Key Trial Info

Start Date :

March 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2021

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT04078581

Start Date

March 1 2020

End Date

June 1 2021

Last Update

July 3 2023

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.